Premium Nahrungsergänzungsmittel | artgerecht

Promyelocyte – Definition, Function & Significance

A promyelocyte is an immature precursor cell of white blood cells that develops in the bone marrow. It plays a key role in the formation of granulocytes.

Regular tips about health Regular tips about health

Things worth knowing about "Promyelocyte"

A promyelocyte is an immature precursor cell of white blood cells that develops in the bone marrow. It plays a key role in the formation of granulocytes.

What Is a Promyelocyte?

A promyelocyte is an immature cell of the myeloid lineage and represents an important developmental stage in hematopoiesis (blood cell formation). It develops from the myeloblast in the bone marrow and matures further into a myelocyte. Promyelocytes are precursor cells of granulocytes, a group of white blood cells that play a critical role in the immune defense against infections.

Development and Maturation

Blood cell formation begins with pluripotent stem cells in the bone marrow, which progressively develop into mature blood cells through several intermediate stages. In the process of granulopoiesis, the promyelocyte occupies the following position:

Myeloblast (earliest precursor)
Promyelocyte
Myelocyte
Metamyelocyte
Band neutrophil
Segmented neutrophil (mature cell)

The promyelocyte is the largest cell in this developmental sequence. It is characterized by a large, round to oval nucleus and numerous azurophilic granules (primary granules) in the cytoplasm. These granules contain important enzymes such as myeloperoxidase and elastase, which are essential for fighting pathogens.

Clinical Significance

In a healthy individual, promyelocytes remain exclusively in the bone marrow and do not circulate in the peripheral blood. If they are detected in a peripheral blood sample, this may indicate a serious underlying disease.

Acute Promyelocytic Leukemia (APL)

The most well-known disease in which promyelocytes play a central role is acute promyelocytic leukemia (APL). This is a subtype of acute myeloid leukemia (AML) caused by a characteristic chromosomal translocation: the t(15;17) translocation. This results in the fusion of the PML gene (on chromosome 15) and the RAR-alpha gene (on chromosome 17), which blocks normal cell maturation. Immature promyelocytes accumulate in the bone marrow and blood instead of maturing normally.

Typical features of APL include:

Increased bleeding tendency due to disseminated intravascular coagulation (DIC)
Severe fatigue and pallor (anemia)
Increased susceptibility to infections (lack of functional granulocytes)
Presence of Auer rods in blasts on microscopic examination

Other Causes of Elevated Promyelocyte Counts

In addition to APL, promyelocytes can appear in the blood in other conditions, including:

Other forms of acute myeloid leukemia (AML)
Myelodysplastic syndromes (MDS)
Severe infections or sepsis (known as a left shift in the blood count)

Diagnosis

The detection of promyelocytes is typically carried out through the following methods:

Differential blood count: microscopic evaluation of a stained blood smear
Bone marrow aspiration and biopsy: for detailed assessment of cell maturation
Immunophenotyping (flow cytometry): identification of specific surface markers
Cytogenetics and molecular genetics: detection of the t(15;17) translocation when APL is suspected

Treatment for Elevated Promyelocytes

Treatment depends on the underlying condition. In APL, therapy has improved significantly over recent decades:

All-trans retinoic acid (ATRA): promotes the differentiation of blocked promyelocytes into mature granulocytes
Arsenic trioxide (ATO): targets leukemic cells and supports their maturation or programmed cell death (apoptosis)
Chemotherapy: used as an adjunct in certain high-risk patient groups

APL is now considered one of the most treatable forms of acute leukemia, with very high remission rates when diagnosed and treated promptly.

References

Lo-Coco F et al.: Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia. New England Journal of Medicine, 2013; 369:111-121. DOI: 10.1056/NEJMoa1300874.
World Health Organization (WHO): Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th Edition, IARC Press, Lyon, 2017.
Hoffbrand AV, Moss PAH: Hoffbrand's Essential Haematology. 7th Edition, Wiley-Blackwell, 2016.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.